Paramount Group, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q3 2025.

Symbol
PGRE on NYSE
Location
New York, NY
Fiscal year end
31 December
Latest financial report
29 Oct 2025

Shareable Research Card

PGRE - Paramount Group, Inc. Financial Facts

PGRE - Paramount Group, Inc. has a source-backed company facts page for reviewing reported financial metrics, periods, and linked metric histories.

Start with the latest metric summary, then open metric histories or cross-company rankings to compare the same SEC-backed facts.

Context
Latest metrics period: Q3 2025
Latest reported value
Return On Equity -3.1%

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.

Open stable link Open latest 10-Q/10-K hub Which companies report the highest revenue?

Quick Takeaways

  • PGRE - Paramount Group, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q3 2025.
  • Headline metric: Return On Equity -3.1%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-51%</span>.
  • Most recent SEC facts end date: 15 Oct 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Source Evidence

Based on latest 10-Q/10-K

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.

See Original Filing

Latest SEC snapshot (2025-10-15) highlights Return On Equity -3.1%, Return On Assets -1.2%, and Debt-to-equity 1.26x.

Compare This Company Through SEC-backed Metrics

Use these links to compare PGRE - Paramount Group, Inc. against other SEC filers on the same metric, then verify the company history from the paired facts page.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

26.1/100

Weak Confidence medium

Return On Equity

-3.1%

Metric score 0.0/100

Return On Assets

-1.2%

Metric score 0.0/100

Financial Health

Debt to Equity
1.26x

Strengths

NetIncomeLoss YoY

Watchpoints

Return On Equity, Return On Assets, and Revenues YoY

Key metrics snapshot

Return On Equity

-3.1%

YoY: -51%

Industry median: 3.2% (n=269)

View history

Return On Assets

-1.2%

YoY: -53%

Industry median: 1% (n=278)

View history

Debt-to-equity

1.26x

YoY: +3.5%

Industry median: 1.54x (n=241)

View history

Revenues YoY

-28%

YoY:

Industry median: 2.8% (n=231)

View history

NetIncomeLoss YoY

54%

YoY:

Industry median: 0.74% (n=239)

View history

Profitability

Metric Latest value YoY change
Return On Equity -3.1% -51%
Return On Assets -1.2% -53%

Financial Health

Metric Latest value YoY change
Debt-to-equity 1.26x +3.5%

Growth

Metric Latest value YoY change
Revenues YoY -28%
NetIncomeLoss YoY 54%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 221,897,427 +2%
Common Stock, Shares, Outstanding 221,897,427 +2%
Common Stock, Value, Issued $2,219,000 +2%
Weighted Average Number of Shares Outstanding, Basic 220,512,867 +1.5%
Weighted Average Number of Shares Outstanding, Diluted 220,512,867 +1.5%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $17,921,000 -28%
General and Administrative Expense $74,507,000 +14%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $104,770,000 +60%
Income Tax Expense (Benefit) $700,000 -143%
Earnings Per Share, Basic 0 +54%
Earnings Per Share, Diluted 0 +54%
Cash and Cash Equivalents, at Carrying Value $330,207,000 +3.6%
Assets $7,974,495,000 +1.1%
Liabilities $3,898,207,000 +1.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0
Stockholders' Equity Attributable to Parent $3,023,937,000 -4.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $4,076,288,000 +0.61%
Liabilities and Equity $7,974,495,000 +1.1%
Share-based Payment Arrangement, Noncash Expense $18,763,000 -14%
Common Stock, Shares Authorized 900,000,000 0%
Common Stock, Shares, Issued 221,897,427 +2%
Common Stock, Par or Stated Value Per Share 0.01 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $654,357,000 +33%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $95,642,000 +61%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY